Alliance Global Partners Maintains Buy on Tonix Pharmaceuticals, Raises Price Target to $18
Alliance Global Partners Maintains Buy on Tonix Pharmaceuticals, Raises Price Target to $18
Alliance Global Partners維持對Tonix Pharmicals的買
Alliance Global Partners analyst James Molloy maintains Tonix Pharmaceuticals (NASDAQ:TNXP) with a Buy and raises the price target from $6.5 to $18.
Alliance Global Partners分析師詹姆斯·莫洛伊維持Tonix製藥（納斯達克股票代碼：TNXP）的買入，並將目標股價從6.5美元上調至18美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。